MedTrace Logo

Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?

NCT02051244 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-01-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether by measuring changes in the thickness of the retinal nerve fibre layer (the photosensitive layer at the back of the eye) you could predict if someone would develop Alzheimer's disease in the future. The measurement is made by OCT (ocular coherence tomography), a noninvasive and relatively inexpensive test that uses light waves to scan the back of the eye.

Conditions

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Geyer Orna, MD · Professor of Ophthalmology Carmel Medical Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02051244 on ClinicalTrials.gov